TT Patents & Techno Offers

The reference network in R+D+i Energy for Society (XRE4S) has a portfolio with more than 30 technological solutions in the energy sector ready to be implemented and present to companies and investors. 

The patent is yet to be licensed and could aid in the development of the supercapacitor industry.

The catalogue offers licensing and commercialization opportunities for companies and welcomes investors and spin offs.

In 2019 the ICMAB applied for 4 priority patent applications, all of them European, and for an extension in Europe of a French priority patent. This means that from the 34 European patent applications from the CSIC, 5 are from the ICMAB (nearly 15 %). The CSIC leads the European patents applied in Spain, and there is a new record of European patent applications from Spanish origin according to the 2019 Patent Index of the European Patent Office (EPO). 

Magnetic resonance imaging (MRI) is a commonly used clinical imaging technique for noninvasive diagnosis and characterization of soft tissues. The technique provides images in excellent detail of tumors and related pathological conditions thanks to the contrast agents used in the procedure. Now, a group of researchers from the ICMAB led by José Vidal-Gancedo, from the Nanomol Group, have developed organic metal-free magnetic resonance imaging (MRI) contrast agents based on dendrimers with a totally innovative synthesis procedure.

A technology developed by a team led by Dr. Núria Crivillers, researcher at the Nanomol Group at ICMAB, has been selected as a high potential innovation by the European Union (EU).